In the January 2020 edition of STAT News was a news release from 215 biopharma CEOs and industry leaders. The news release leverages 2020 as the beginning of “the dawn of a golden age of medicine [which] will soon have the ability to treat and cure diseases that have long been untreatable and incurable.” [...]
Crystal Lake, Illinois, October 31, 2019 – AptarGroup, Inc. (NYSE: ATR), a global leader in consumer dispensing, active packaging and drug delivery solutions, announced today that, subsequent to the end of the quarter, it has acquired Noble International, a leader in drug delivery training devices and patient onboarding. This acquisition furthers Aptar’s strategy to [...]
Last year, Medgadget heard from Noble International about its smart training devices that educate patients on safe and effective at-home use of prefilled syringes and autoinjectors. At the time, Joe Reynolds, Research Manager at Noble International, shared some use cases for the company’s products, including rheumatoid arthritis (RA). Since that interview, longitudinal data has proven the efficacy [...]
Millions of patients worldwide living with rare, debilitating conditions are benefiting from developments in biopharmaceuticals and complex chemical entities as well as novel approaches to drug delivery. For example, many therapeutics administered in a subcutaneous injection are suitable for at-home administration by patients themselves, rather than in a healthcare facility. This includes wearable injection [...]
Chronic illnesses are on the rise, which means there are more and more patients who need to self-inject treatments at home. The problem is that patients who lack confidence in using their drug-delivery device or are inadequately familiar with the device tend to use it incorrectly and may not be receiving the full dose [...]
Participants in a study by the company Noble show that the vast majority of patients—92%—would prefer to bring home a training device to practice with prior to starting self-injection. Noble creates trainers for autoinjectors intended to increase patient confidence and autonomy with self-managed treatments. Watch full clip>
Desperate for relief, many people living with inflammatory bowel disease (IBD)—either Crohn’s disease or ulcerative colitis—rely on biologic therapies that require users to self-inject. Because self-injecting can be a daunting task—evidenced by the 45% of patients who skip or altogether avoid injections due to anxiety or fear—proper training and onboarding is critical. Even more [...]
Ensuring that diabetes patients correctly administer their insulin or glucagon is a priority for prescribers and patients alike. Keeping tabs on the extent to which patients are (or are not) taking their medications as prescribed, however, is increasingly complicated due to technical innovations in drug delivery. Read full article >
Desperate for relief, many people living with psoriasis and atopic dermatitis rely on biologic therapies that require users to self-inject. Because self-injecting can be a daunting task—evidenced by the 45% of patients who skip or altogether avoid injections due to anxiety or fear—proper training and onboarding is critical. Even more alarming is that nearly [...]
Desperate for relief, many people living with rheumatoid arthritis (RA) and other chronic conditions rely on biologic therapies that require users to self-inject. Because self-injecting can be a daunting task—evidenced by the 45% of patients who skip or altogether avoid injections due to anxiety or fear—proper training and onboarding is critical. Even more alarming [...]